Osteoporosis is an important comorbidity in patients with chronic kidney disease (CKD). Compared with individuals who do not have CKD, the prevalence of osteoporosis and the risk of fractures is higher in individuals with CKD.1,2 Major bone fractures in patients with CKD are a global health care burden and are often associated with high rates of hospitalization, death, and high health care–associated costs.3,4